SCHEMBL13685285

SCHEMBL13685285

CC1(C)CCCCCCCCC[C@@H](C(=O)C(N)=O)NC(=O)[C@@H]2[C@@H]3C(CN2C(=O)[C@H]1NC1OO1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607088 0.85 — —
SCHEMBL13685097 0.85 — —
SCHEMBL13685073 0.85 — —
SCHEMBL8036422 0.85 — —
SCHEMBL13685067 0.85 — —
SCHEMBL13685056 0.84 CTSV (0.32) —
SCHEMBL13685286 0.84 CTSV (0.32) —
SCHEMBL12607085 0.84 CTSV (0.32) —
SCHEMBL13685065 0.83 — —
SCHEMBL13685771 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
Send feedback